Policosanol

12 benefits mapped to clinical evidence across supplements.

Benefit Evidence

Strong

LDL/TC ↓ ~20%

HDL ↑ ~10-30%

4,358 people

Strong

Lipids: LDL↓ HDL↑

Platelets/BP: less clotting

3,675 people

Moderate

Lipids/BP: -25%

+HDL, fewer events

Platelets: -48.7% HPR

2,122 people

Blood circulation

Moderate

Antiplatelet, -70%

Walking, lipids

1,117 people

Moderate

SBP −7 to −14

DBP −14%

1,350 people

Moderate

Lipids: LDL↓ HDL↑

Stroke recovery: mRS↓ 80-88%

Inflammation/platelets↓

823 people

Moderate

Exercise + recovery

Walking +33–69%

424 people

Exercise recovery

Moderate

Walking +55-69%

Stroke recovery mRS↓

424 people

Moderate

Cardiovascular recovery +87.5%

Lipids/claudication better

534 people

Moderate

Lipid oxidation +21%

HDL/LDL shifts

168 people

Energy & Fatigue

Weak

Exercise capacity +VO2max

Walking distance +55-59%

107 people

Weak

↓ BP, ↓ HbA1c

↑ HDL, +6.3%

72 people

Main Effects

LDL/TC ↓ ~20%

HDL ↑ ~10-30%

Strong

4,358

Lipids: LDL↓ HDL↑

Platelets/BP: less clotting

Strong

3,675

Lipids/BP: -25%

+HDL, fewer events

Platelets: -48.7% HPR

Moderate

2,122

Blood circulation

Antiplatelet, -70%

Walking, lipids

Moderate

1,117

SBP −7 to −14

DBP −14%

Moderate

1,350

Lipids: LDL↓ HDL↑

Stroke recovery: mRS↓ 80-88%

Inflammation/platelets↓

Moderate

823

Exercise + recovery

Walking +33–69%

Moderate

424

Exercise recovery

Walking +55-69%

Stroke recovery mRS↓

Moderate

424

Cardiovascular recovery +87.5%

Lipids/claudication better

Moderate

534

Lipid oxidation +21%

HDL/LDL shifts

Moderate

168

Energy & Fatigue

Exercise capacity +VO2max

Walking distance +55-59%

Weak

107

↓ BP, ↓ HbA1c

↑ HDL, +6.3%

Weak

72